Neuroscience
Peripheral Neuropathy
100%
Myasthenia gravis
51%
Polyneuropathy
50%
Eculizumab
41%
Intravenous Immunoglobulin
35%
Peripheral Neuropathy
29%
Amyotrophic Lateral Sclerosis
28%
Neuromuscular Disorder
27%
Electrodiagnosis
26%
Nerve Block
25%
Placebo
21%
Cisplatin
19%
Rituximab
19%
Diabetic Neuropathy
18%
Wallerian Degeneration
17%
Cholinergic Receptor Antibody
16%
Peripheral Nerve
15%
Amifostine
15%
Immunosuppressive Drug
15%
Nerve Conduction
14%
Neurotoxicity
13%
Paclitaxel
12%
Intraexaminer Reliability
11%
Globulin
11%
Quantitative Sensory Testing
11%
Peripheral Nervous System
10%
Diabetes Mellitus
8%
2 Amino 4 (Methylsulfonyl)butyrylglutamylhistidylphenylalanyl Dextro Lysylphenylalanine
8%
Myalgia
8%
Vitamin E
8%
Chemoprotective Agent
8%
Muscle Disorder
7%
Multiple Sclerosis
7%
Human Immunoglobulin
7%
Neuromuscular
7%
Nerve Conduction Study
6%
Epitope
6%
Immunosuppressant
6%
Motor Neuron
6%
Glutathione
6%
Randomized Controlled Trial
6%
Mycophenolate Mofetil
6%
Polymyositis
6%
Central Nervous System
6%
Tyrosine Kinase
5%
Quadriplegia
5%
Paraparesis
5%
Talampanel
5%
Aquaporin 4
5%
Neuromuscular Junction
5%
Keyphrases
Neuropathy
54%
Myasthenia Gravis
31%
Intravenous Immunoglobulin (IVIg)
25%
Multifocal Motor Neuropathy
25%
Eculizumab
23%
Peripheral Neuropathy
21%
Cisplatin
19%
Amyotrophic Lateral Sclerosis
19%
Technology Assessment
17%
Open-label Extension
17%
Chronic Inflammatory Demyelinating Polyneuropathy
17%
Guillain-Barré Syndrome
15%
Neuromuscular Disease
14%
Rituximab
12%
Toxic Neuropathy
12%
Quantitative Sensory Testing
12%
Long-term Safety
11%
American Academy of Neurology
11%
Long-term Efficacy
11%
Therapeutic Assessment
11%
Related Compounds
11%
Amifostine
11%
Electrophysiological Study
11%
Diabetic Neuropathy
11%
Thalidomide
11%
Nerve Conduction Studies
10%
Diethyldithiocarbamate
10%
Electrodiagnosis
10%
Vitamin E
9%
Neurotoxicity
9%
Peripheral Nerve
9%
Demyelinating Neuropathy
8%
Polyneuropathy
8%
Total Neuropathy Score
8%
Demyelination
7%
Conduction Block
7%
IV Immunoglobulin
7%
Taxol
7%
Peripheral Nerve Defect
7%
Idiopathic Inflammatory Myopathies
7%
Chronic Liver Disease
7%
Glutathione
7%
Chemotherapy
7%
Acetylcholine Receptor Antibody
7%
Neurotrophin-3 (NT-3)
7%
Motor Neuropathy
6%
Wallerian Degeneration
6%
Placebo
6%
Suramin
5%
Lumbosacral Plexopathy
5%
Medicine and Dentistry
Neuropathy
42%
Electrodiagnosis
32%
Disease
28%
Neuromuscular Disease
25%
Peripheral Nerve
23%
Amyotrophic Lateral Sclerosis
23%
Weakness
21%
Polyneuropathy
20%
Neurology
19%
Technology Assessment
17%
Nerve Block
16%
Myasthenia gravis
15%
Multifocal Motor Neuropathy
13%
Placebo
13%
Diabetic Neuropathy
12%
Areflexia
12%
Diagnosis
12%
Cholinergic Receptor Antibody
11%
Eculizumab
11%
Plexopathy
11%
Immunosuppressive Drug
11%
Peripheral Neuropathy
11%
Symptom
11%
Liver Disease
10%
Immunoglobulin
9%
Demyelination
9%
Drug Therapy
8%
Clinical Feature
8%
Tetraplegia
7%
Chronic Liver Disease
7%
Myositis
7%
Denervation
7%
Electromyography
7%
Nerve Compression
7%
Immunosuppressive Treatment
6%
Autoimmune Disease
6%
Patisiran
5%
Ulnar Nerve
5%
Motor Neuron Disease
5%
Paralysis
5%
Patient History of Chemotherapy
5%
Paclitaxel
5%
Liver Cirrhosis
5%
Child-Pugh Score
5%
Excitability
5%
Nerve Lesion
5%
Motor Evoked Potential
5%
Sensorimotor Neuropathy
5%
Transthyretin
5%
Retigabine
5%
